Aponia Laboratories, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2010-01-01
- Employees
- 1
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS
Phase 2
Completed
- Conditions
- Pain, Acute
- Interventions
- Drug: S-IbuprofenDrug: Vehicle
- First Posted Date
- 2019-02-25
- Last Posted Date
- 2022-01-25
- Lead Sponsor
- Aponia Laboratories, Inc.
- Target Recruit Count
- 251
- Registration Number
- NCT03852459
- Locations
- 🇺🇸
JBR Clinical Research, Salt Lake City, Utah, United States
Phase II Study of AP0302 5% Versus a Vehicle Comparator
Phase 2
Completed
- Conditions
- PainDelayed Onset Muscle Soreness
- Interventions
- Drug: S-Ibuprofen Topical Gel 5%Drug: Vehicle Topical Gel
- First Posted Date
- 2014-12-24
- Last Posted Date
- 2019-02-25
- Lead Sponsor
- Aponia Laboratories, Inc.
- Target Recruit Count
- 147
- Registration Number
- NCT02324985
- Locations
- 🇺🇸
Lotus Clinical Research, LLC, Pasadena, California, United States
News
No news found